Introduction
============

G protein coupled receptors (GPCR), by activating heterotrimeric guanine nucleotide-binding proteins (G-proteins), control an array of cellular functions ([@B14]). G-proteins are composed of α, β and γ subunits. In the inactive state, the GDP-bound Gα subunit is associated to the Gβγ heterodimer. Ligand binding of a GPCR acts as guanine-nucleotide exchange factors (GEFs) that activate trimeric G-proteins, leading the exchange of GDP in GTP on the Gα subunit, its dissociation from Gβγ dimer, and thereby enabling both Gα and Gβγ subunits to modulate a wide range of downstream signaling ([@B6]). GPCR cascade is ended by the regulator of G-protein signaling (RGS) proteins, which accelerate the GTP hydrolysis on the Gα subunits, thereby promoting their inactivation. In the nervous system, the control of GPCR signaling is achieved by the members of the R7 subfamily of RGS proteins (R7-RGS). A hallmark of R7-RGS protein organization is their association with Gβ5, encoded by GNB5, a divergent member of the beta subunits of heterotrimeric G proteins ([@B3]; [@B10]).

In humans, variants in each of the five distinct G proteins β-subunits (*GNB1*-*5*) cause developmental delays and/or heart rhythm disorders. Germline *GNB1* variants cause severe neurodevelopmental disability, hypotonia, and seizures ([@B12]); *GNB2* variants cause sinus node and atrioventricular conduction dysfunction ([@B16]); *GNB3* bi-allelic loss-of-function variants cause congenital stationary night blindness ([@B20]), recessive retinopathy ([@B2]), and a reduced cone sensitivity with bradycardia([@B17]; [@B23]); finally, *GNB4* variants cause a dominant form of Charcot-Marie-Tooth disease ([@B15]).

Recently, others and we identified homozygous or compound heterozygous variants in the *GNB*5 gene that are associated with either IDDCA (MIM\#617173) or LADCI (MIM\#617182), in which the severity of the phenotype correlates with the type of the genetic variant ([@B9]; [@B13]). Specifically, homozygous carriers of the most frequent missense variant p.(Ser81Leu) are characterized by mild intellectual disability in combination with language delay, attention-deficit/hyperactivity disorder, with or without cardiac arrhythmia (LADCI) ([@B13]). In contrast, homozygous carriers of null alleles showed the severe IDDCA neurological phenotype including epileptic seizures, intellectual disability, retinal abnormalities, hypotonia, and sick sinus syndrome ([@B9]). Consistent with the manifestations of IDDCA patients, phenotypic characterization of *Gnb5* loss in mice and our zebrafish *gnb5* knockout showed, respectively, abnormalities of neuronal development, including hyperactivity and an altered motor capacity, impaired ocular response, and cardiac sinus node dysfunction ([@B4]; [@B21]; [@B24]; [@B22]; [@B9]), corroborating the importance of *GNB5* for neuronal signaling and parasympathetic regulation of heart rate as well as vision and motor function.

After the first cases described ([@B9]; [@B13]) additional cases have been reported ([@B18]; [@B19]). Here we report a new patient with compound heterozygosity for the p.(Asp74Glufs^∗^52) frameshift variant and the p.(Ser81Leu) missense variant in *GNB5*. Her clinical features are consistent with a moderate phenotype, suggesting the direct correlation between the type and likely the mechanism of the *GNB5* genetic variant and the severity of phenotype.

Background
==========

Case Report
-----------

We describe a 2.5-year-old female proband, born from non-consanguineous and healthy parents of Caucasian ancestry (Figure [1A](#F1){ref-type="fig"}). The child was the product of a 35-week gestation pregnancy that was complicated by fetal bradycardia and intrauterine growth retardation that prompted an emergency C-section. The family history was negative for developmental delay, sick sinus syndrome, and epilepsy, with the exception of a maternal uncle and a paternal first-cousin, both suspected to have autism spectrum disorder.

![**(A)** Family pedigree investigated in this study. Filled symbols represent: hypotonia (bottom left quarter), severe sick sinus syndrome (SSS; top left quarter), seizure (bottom right quarter), and intellectual disability (ID; top right quarter). **(B)** Distribution of the GNB5 variants (NM_006578) across the gene with exons indicated by gray boxes. The frameshift variants are designated in bold, missense variants are in gray, and nonsense variants are in black. The number of patients with each variant is indicated in parentheses. **(C)** Schematic representation of the GNB5 protein with Coiled coil and WD-40 repeats domains.](fgene-09-00626-g001){#F1}

At birth she required positive-pressure ventilation for 3 min. Apgar scores at 1 and 5 min were 1 and 7, respectively. Birth weight was 1698 g (\<1st percentile). She was hospitalized for 3 weeks in the neonatal intensive care unit for prematurity and intrauterine growth restriction being less than 2000 grams. Due to her feeding difficulties, she was fed by nasogastric tube. After 20 days she was discharged home on full oral feeds. At 8 months of age she was noted to have plagiocephaly associated with torticollis, solved with molding helmet therapy. The typical developmental milestones were not met at 1 year of age. When she was 13 months old her gross motor skills were noted to be at the 10-month level, her fine motor skills and receptive language skills were at the 9-month level, and her expressive language skills were at the 5-month level, indicating delays of 3 to 8 months. At 15 months, her developmental quotient, calculated by Capute scores ([@B1]) was between 50 and 55; therefore, her psychomotor delay was assessed as ranging between mild to moderate.

She had strabismus, which was surgically corrected at 16 months. At the same age, she also had implantation of bilateral tympanostomy tubes. Following intensive therapies, her developmental skills have improved. She began walking independently at 18 months. Additionally, she has hypotonia, a wide-based gait, and poor balance. She was described as falling more frequently than expected. However, her communication, particularly expressive language skills, represents the biggest challenge. Currently, her spoken vocabulary consists of about 12 words, and she can also use some sign language. She is social, curious, and interactive and has a high activity level and short attention span compared to peers.

Following identification of her *GNB5* variants and the reported clinical spectrum of IDDCA which includes early-onset sick sinus syndrome and epileptic encephalopathy among other cardinal manifestations, the patient was referred to cardiology and neurology.

An electrocardiogram (ECG) showed sinus bradycardia with heart rate of ∼50 at the age of 18 months. A 24-h Holter monitor showed evidence of sinus node dysfunction, with over 3,000 sudden rate drops and pauses that exceeded 3 s. A pacemaker was placed at 2 years of age. Her frequent falls and poor balance improved after pacemaker placement, raising the possibility that those falls were related to sinus pauses. The neurologic evaluation was normal; no evidence of epileptic encephalopathy was detected. Due to lack of relevant clinical findings, an EEG was not performed.

Materials and Methods {#s1}
=====================

As no potentially pathogenic genomic structural abnormalities were identified by SNP array-CGH of the subject, genomic DNA from the proband and her parents were analyzed by next-generation sequencing using the Autism/ID Xpanded Panel (GeneDx^[1](#fn01){ref-type="fn"}^) on an Illumina sequencing System. Reads were aligned to human genome build GRCh37/UCSC hg19, and analyzed for sequence variants in targeted genes using a GeneDx custom-developed analysis tool (Xome Analyzer). Sequence and copy number alterations were reported according to the Human Genome Variation Society (HGVS) and International System for Human Cytogenetic Nomenclature (ISCN) guidelines, respectively.

The patient's biospecimens (DNA and skin fibroblast cell lines) are stored at Genomic Disorder Biobank, member of the Telethon Network of Genetic Biobanks ([@B5]; [@B11]). This study was carried out in accordance with the recommendations of the University of Virginia Institutional Review Board for Health Sciences Research. The subject gave written informed consent in accordance with the Declaration of Helsinki. Written informed consent was obtained from the parent of the patient for the publication of this case.

Molecular Results
-----------------

The proband's results were compound heterozygous for a maternally inherited missense substitution \[c.242C \> T; p.(Ser81Leu)\], and a paternally inherited frameshift variant \[c.222_226delTAAGA; p.(Asp74Glufs^∗^52)\] in the *GNB5* gene (NM_006578.3) (Figure [1](#F1){ref-type="fig"}). Both variants were confirmed by Sanger Sequencing and have already been identified in IDDCA affected individuals. Eight p.(Ser81Leu) homozygous patients, from three different families, have been already described ([@B9]; [@B13]). The pathogenicity of this allele is supported by *in silico* modeling and functional studies. The replacement of the evolutionary conserved Serine 81 with hydrophobic Leucine, buried into the first WD40 protein domain (WD1), would abolish hydrogen bond formation with V108 and bulkier side chain of Leucine at this position would not fit into the tightly packed antiparallel β-sheet of WD1 ([@B13]). Thus, S81L substitution is predicted to induce localized structural changes that might compromise protein folding and/or stability as well as impair the binding kinetics of RGS proteins ([@B9]), and its capacity to deactivate G-protein signaling initiated by dopamine receptors ([@B13]).

The c.222_226delTAAGA; p.(Asp74Glufs^∗^52) variant, absent in ExAC, has been reported as causative of IDDCA in a recent study ([@B19]). This variant is predicted to be loss of function (lof) because losing these nucleotides creates a premature stop codon of the protein after 50 amino acid residues, which is positioned in the second WD-40 domain (Figure [1](#F1){ref-type="fig"}).

Discussion
==========

The GNB proteins are expressed in different and specific tissues and interact with many effectors to elicit a wide range of specific cellular responses. Therefore it is not surprising for variants that alter G-proteins functions to compromise the appropriate cellular response, which is associated with aberration of physiological functions, and thus linked with a predisposition to develop human diseases. In humans, variants in each of the five distinct G proteins β-subunits (*GNB1*-*5*) cause rare genetics diseases.

Here we described the second case of a patient who is a compound heterozygote for a null and a missense variant in *GNB5*. Although the number of identified *GNB5* pathogenic variants is still small, there is a hot spot for *GNB5* variants in exon 2 (55% of identified pathogenetic variants), encoding the first WD40 protein domain of the seven that characterize *GNB5* (Figures [1B,C](#F1){ref-type="fig"}). The WD40 domain shows a β-propeller structure that provides a stable scaffold for protein-protein interaction and is involved in a variety of cellular functions including signal transduction autophagy, and apoptosis ([@B8]). Variants in WD40 domains are associated with an increasing number of human diseases, reviewed in ([@B7]). Of relevance, all the *GNB5* variants reported so far affect highly conserved amino acid residues and WD40 domains that may impair the correct GNB5 protein folding, compromising its function and then the cellular downstream processes leading to the clinical phenotype seen in the patients.

Although more patients are needed to definitively establish a genotype-phenotype correlation, some preliminary speculation has been made. For instance, most patients with missense variants, commonly the p.(Ser81Leu) variant, have mild ID and do not have epileptic encephalopathy (Table [1](#T1){ref-type="table"}). In contrast, the majority of patients carrying lof *GNB5* alleles have early infantile developmental and epileptic encephalopathy as well as more significant ID. There is only one other patient in the literature who is compound heterozygous for a missense and lof GNB5 variant ([@B19]). Our patient appears to have more mild clinical and neurological manifestations than this previously described patient. Features in common include psychomotor delay and sinus pauses. His psychomotor delay is more significant, however, since he is nonverbal and unable to sit independently at 17 months. He is also described as having laryngomalacia, hearing loss, and a reduction in cone and rod function; none of these phenotypes are present in our patient.

###### 

Clinical features of GNB5-patients reported so far.

                                 [@B9] Family A II.1                        [@B9] Family A II.2             [@B9] Family B II.1               [@B9] Family C II.2                                                                   [@B9] Family C II.3                [@B9] Family D II.2                                  [@B9] Family E II.1                                  [@B9] Family E II.2                                                                                 [@B9] Family F II.1
  ------------------------------ ------------------------------------------ ------------------------------- --------------------------------- ------------------------------------------------------------------------------------- ---------------------------------- ---------------------------------------------------- ---------------------------------------------------- --------------------------------------------------------------------------------------------------- ---------------------------------------------------
  Paternal allele                c.249G \> A p.Asp84Valfs^∗^52              c.249G \> A p.Asp84Valfs^∗^52   c.249+1G \> T p.Asp84Leufs^∗^31   c.249+3A \> G p.Asp84Valfs^∗^31                                                       c.249+3A \> G p.Asp84Valfs^∗^31    c.906C \> G p.Tyr302^∗^                              c.242C \> T p.Ser81Leu                               c.242C \> T p.Ser81Leu                                                                              c.242C \> T p.Ser81Leu
  Maternal allele                c.994C \> T p.Arg332^∗^                    c.994C \> T p.Arg332^∗^         c.249+1G \> T p.Asp84Leufs^∗^31   c.249+3A \> G p.Asp84Valfs^∗^31                                                       c.249+3A \> G p.Asp84Valfs^∗^31    c.906C \> G p.Tyr302^∗^                              c.242C \> T p.Ser81Leu                               c.242C \> T p.Ser81Leu                                                                              c.242C \> T p.Ser81Leu
  Gender, age (years)            F, 24                                      F, 22                           F, 8                              F, 13                                                                                 M, 11                              F, 14                                                F, 15                                                M, 10                                                                                               M, 25
  Birth weight (percentile)      3,580 g (50th)                             NA                              2,980 g (15th)                    2,751 g (15th)                                                                        NA                                 2,845 g (15th)                                       NA                                                   NA                                                                                                  NA
  Ethnicity                      Italy                                      Italy                           Jordan                            Puerto Rico                                                                           Puerto Rico                        India                                                Morocco                                              Morocco                                                                                             Brazil
  Consanguinity                  \-                                         \-                              \+                                \+                                                                                    \+                                 \-                                                   \-                                                   \-                                                                                                  \+
  Verbal understanding           NA                                         NA                              nonverbal                         unremarkable                                                                          unremarkable                       NA                                                   NA                                                   NA                                                                                                  NA
  Speech Development             \+                                         \+                              nonverbal                         nonverbal                                                                             delayed                            nonverbal                                            \+                                                   \+                                                                                                  NA
  Intellectual disability (ID)   Severe ID                                  Severe ID                       Severe ID                         Severe ID                                                                             Global developmental delay         Severe ID                                            Mild ID                                              Mild ID                                                                                             Mild ID
  Epilepsy                       \+                                         \+                              \+                                \-                                                                                    \-                                 \+                                                   \-                                                   \-                                                                                                  \-
  Retinal Disease                NA                                         Retinal degeneration            NA                                NA                                                                                    NA                                 NA                                                   NA                                                   NA                                                                                                  Keratoconus
  Nystagmus                      \+                                         \+                              \+                                \+                                                                                    \+                                 \+                                                   NA                                                   \-                                                                                                  NA
  Sinus sick syndrome            \+                                         Bradyarrhythmia                 \+                                \+                                                                                    \+                                 increased PR interval/                               \+                                                   \+                                                                                                  \+
                                                                                                                                                                                                                                                                       (intermittent Wenckebach)                                                                                                                                                                                     
  Minimum heart rate (bpm)       24                                         39                              NA                                paced                                                                                 paced                              NA                                                   20                                                   16                                                                                                  
  Maximum heart rate (bpm)       163                                        192                             NA                                paced (27% heartbeats on Holter)                                                      paced (20% heartbeats on Holter)   NA                                                   176                                                  180                                                                                                 NA
  Chronotropic response          NA                                         NA                              NA                                \+                                                                                    \+                                 NA                                                   unremarkable                                         unremarkable                                                                                        NA
  Escape beats                   \+                                         \+                              NA                                paced                                                                                 paced                              NA                                                   \+                                                   \+                                                                                                  NA
  Pacemaker implantation         \-                                         \-                              \-                                \+                                                                                    \+                                 \-                                                   \-                                                   \+                                                                                                  NA
  Cardiac anomalies              \-                                         PFO                             NA                                \-                                                                                    \-                                 \-                                                   \-                                                   \-                                                                                                  NA
  Hypotonia                      \+                                         \+                              \+                                \+                                                                                    \+                                 \+                                                   \-                                                   impaired fine motor skills                                                                          \-
  Gastroesophageal Reflux        \+                                         \+                              \-                                \+                                                                                    \+                                 \+                                                   \-                                                   \-                                                                                                  NA
  Others                                                                                                                                      Abnormally mitochondrial shape, focal z-band streaming and type1 fiber predominance                                                                                                                                                                                                                                                    
  Dysmorphic feature(s)                                                                                                                                                                                                                                                                                                                                                                                                                                                              
  Paternal allele                c.242C \> T p.Ser81Leu                     c.242C \> T p.Ser81Leu          c.242C \> T p.Ser81Leu            c.242C \> T p.Ser81Leu                                                                c.242C \> T p.Ser81Leu             c.355delG p.Ala119Profs^∗^16                         c.355delG p.Ala119Profs^∗^16                         c.737G \> A p.Arg246Gln                                                                             c.222_226delTAAGA p.Asp74Glufs^∗^52
  Maternal allele                c.242C \> T p.Ser81Leu                     c.242C \> T p.Ser81Leu          c.242C \> T p.Ser81Leu            c.242C \> T p.Ser81Leu                                                                c.242C \> T p.Ser81Leu             c.355delG p.Ala119Profs^∗^16                         c.355delG p.Ala119Profs^∗^16                         c.222_226delTAAGA p.Asp74Glufs^∗^52                                                                 c.242C \> T p.Ser81Leu
  Gender, age (years)            F, 12                                      F, 11                           F, 5                              F, 7                                                                                  F, 11                              M, 3                                                 F, 11                                                M, 2                                                                                                F, 2.5
  Birth weight (percentile)      50th centile                               50th centile                    NA                                50th centile                                                                          NA                                 NA                                                   1800 g ( \< 1st)                                     3311 g (50th)                                                                                       1698 g ( \< 1st) (Intrauterine growth restricted)
  Ethnicity                      Saudi                                      Saudi                           Saudi                             Saudi                                                                                 Saudi                              NA                                                   NA                                                   European/Caucasian                                                                                  European/Caucasian
  Consanguinity                  \+                                         \+                              \+                                \-                                                                                    \-                                 \+                                                   \+                                                   \-                                                                                                  \-
  Verbal understanding           \+                                         \+                              \+                                \+                                                                                    \+                                 "no developmental milestones"                        "no developmental milestones"                        nonverbal                                                                                           \+
  Speech Development             Severe language delay                      Severe language delay           Severe language delay             Severe language delay                                                                 Severe language delay              "no developmental milestones"                        "no developmental milestones"                        nonverbal                                                                                           expressive speech delay
  Intellectual disability (ID)   Normal IQ, but school performance issues   Normal cognitive development    NA                                Normal IQ                                                                             NA                                 Severe ID                                            Severe ID                                            Severe ID                                                                                           Mild ID
  Epilepsy                       NA                                         NA                              NA                                NA                                                                                    NA                                 \+                                                   \+                                                   \-                                                                                                  \-
  Retinal Disease                NA                                         NA                              NA                                NA                                                                                    NA                                 Retinal degeneration                                 Retinal degeneration                                 Severe reduction in cone and rode function                                                          \-
  Nystagmus                      NA                                         NA                              NA                                NA                                                                                    NA                                 \+                                                   \+                                                   \+                                                                                                  Strabismus
  Sinus sick syndrome            NA                                         NA                              NA                                NA                                                                                    NA                                 Sinus arrhythmia/ Sinus bradycardia                  Sinus arrhythmia/ Sinus bradycardia                  Sinus arrhythmia/ Sinus bradycardia                                                                 \+
  Minimum heart rate (bpm)       NA                                         NA                              NA                                NA                                                                                    NA                                 NA                                                   NA                                                   71                                                                                                  36
  Maximum heart rate (bpm)       NA                                         NA                              NA                                NA                                                                                    NA                                 NA                                                   NA                                                   183                                                                                                 176
  Chronotropic response          NA                                         NA                              NA                                NA                                                                                    NA                                 NA                                                   NA                                                   NA                                                                                                  NA
  Escape beats                   NA                                         NA                              NA                                NA                                                                                    NA                                 NA                                                   NA                                                   \+ (prior to pacing)                                                                                \+
  Pacemaker implantation         NA                                         NA                              NA                                NA                                                                                    NA                                 Refused by parents                                   Refused by parents                                   \+                                                                                                  \+
  Cardiac anomalies              NA                                         NA                              NA                                NA                                                                                    NA                                 \-                                                   \-                                                   \-                                                                                                  \-
  Hypotonia                      \-                                         \-                              NA                                \+                                                                                    NA                                 \+                                                   \+                                                   \+                                                                                                  \+
  Gastroesophageal Reflux        NA                                         NA                              NA                                NA                                                                                    NA                                 normal (abdominal US examination)                    normal (abdominal US examination)                    \+                                                                                                  \-
  Others                         ADHD, Hyperactivity                        Inattentive type ADHD           Motor delay                       Motor delay                                                                           ADHD, mild motor delay             autistic (midline hand automatism, no eye contact)   autistic (midline hand automatism, no eye contact)   center-sided hearing loss, hypertonia, upper extremity jerking motions, laryngomalacia hypertonia   tympanostomy tubes
  Dysmorphic feature(s)                                                                                                                                                                                                                                                prominent forehead, micro-brachycephaly (acquired)   prominent forehead, micro-brachycephaly (acquired)   thin corpus callosum (brain MRI)                                                                    
                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     

M, male: F, female; NA, not available; +, clinical trait present; -, clinical trait not present; bpm, beats per minute; ADHD, attention deficit hyperactivity disorder; PFO, patent foramen ovale; US, ultrasound.

These two patients have the same p.(Asp74Glufs^∗^52) lof variant; however, our newly reported patient has the commonly reported p.(Ser81Leu) missense variant whereas the patient described in [@B19] has a novel c.737G \> A variant. The latter might affect splicing and, although experimental assays are needed, it could cause a lof, a type of variant more consistent with the phenotype seen in that patient.

This study corroborates the direct correlation between the type of the *GNB5* genetic variant and the severity of related phenotype. Individuals with missense variants, both in homozygous or compound heterozygous states, present with a less severe/moderate phenotype characterized mainly by sinus node dysfunction in combination with mild intellectual disabilities; whereas individuals homozygous for null alleles have severe ID, global developmental delay including early infantile developmental and epileptic encephalopathy, hypotonia, as well as sinus node dysfunction ([@B9]).

Concluding Remarks
==================

This report extends the number of individuals carrying GNB5 pathogenic variant, and demonstrates the phenotypic consequences of heterotrimeric G-proteins deficiency and their critical roles in neuronal and cardiac manifestations. Additional patient studies will help us to more consistently predict phenotype based on their molecular results. Similarly, the combination of functional studies and cellular modeling of the disease (e.g., iPSC-derived heart and brain lineage cells) will provide new insights on the pathogenesis of the disease.
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